3-(2-(9-methoxy-2-p-tolyl-5H-chromeno[2,3-d]pyrimidin-4-ylthio)acetamido)benzoic acid

ID: ALA4575982

Chembl Id: CHEMBL4575982

PubChem CID: 155564318

Max Phase: Preclinical

Molecular Formula: C28H23N3O5S

Molecular Weight: 513.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc2c1Oc1nc(-c3ccc(C)cc3)nc(SCC(=O)Nc3cccc(C(=O)O)c3)c1C2

Standard InChI:  InChI=1S/C28H23N3O5S/c1-16-9-11-17(12-10-16)25-30-26-21(14-18-5-4-8-22(35-2)24(18)36-26)27(31-25)37-15-23(32)29-20-7-3-6-19(13-20)28(33)34/h3-13H,14-15H2,1-2H3,(H,29,32)(H,33,34)

Standard InChI Key:  MLSKDMIWJGIPFP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4575982

    ---

Associated Targets(Human)

UCK2 Tbio Uridine-cytidine kinase 2 (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 513.58Molecular Weight (Monoisotopic): 513.1358AlogP: 5.59#Rotatable Bonds: 7
Polar Surface Area: 110.64Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.99CX Basic pKa: 3.11CX LogP: 6.01CX LogD: 3.19
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.21Np Likeness Score: -1.34

References

1. Okesli-Armlovich A, Gupta A, Jimenez M, Auld D, Liu Q, Bassik MC, Khosla C..  (2019)  Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.,  29  (18): [PMID:31420268] [10.1016/j.bmcl.2019.08.010]

Source